Bird flu vaccine study aims to find best shot schedule
NCT ID NCT07275060
First seen Jan 05, 2026 · Last updated May 25, 2026 · Updated 19 times
Summary
This study looks at a vaccine for H5N1 bird flu, given as two doses either 3 or 8 weeks apart. About 312 healthy adults aged 18-59 will take part to see which timing provides better protection. The goal is to find the most effective way to use this already-approved vaccine in case of an outbreak.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AVIAN INFLUENZA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CHU de Québec
Québec, Quebec, G1E 7G9, Canada
-
Canadian Center for Vaccinology
Halifax, Nova Scotia, Canada
-
Vaccine Evaluation Center
Vancouver, British Columbia, Canada
-
Vaccine Study Centre of the McGill University Health Centre
Pierrefonds, Quebec, H9H 4Y6, Canada
Conditions
Explore the condition pages connected to this study.